Medication for management of pregnancy-induced hypertension

Por um escritor misterioso

Descrição

Hypertension refers to increased arterial blood pressure and can be divided into two categories: primary and secondary. Primary hypertension caused by angiogenic degenerative changes is a degenerative disease. With liberalization of China’s reproduction policy and increases in maternal age, the prevalence of pregnancy-induced hypertension (PIH) in China has increased gradually. PIH is not a type of primary hypertension, but there are differences in the treatment of these two types of hypertension. Here, we review the choice and use of drugs for PIH management using drugs for the management of primary hypertension as a reference. First-line drugs such as labetalol, nifedipine, or methyldopa should be taken via the oral route if blood pressure is ≥ 150/90 mmHg. For chronic hypertension, other drugs should be added after the first drug at the highest concentration has been revealed to be ineffective. If the blood pressure of patients with acute hypertension is ≥ 160/110 mmHg, maternal stroke or eclampsia can result. If PIH patients are about to deliver, they can be given labetalol (i.v.), hydralazine (i.v.) or nifedipine (p.o.). Moreover, all anti-hypertensive treatments should be based on considerations of maternal and fetal safety.
Medication for management of pregnancy-induced hypertension
How should hypertension in pregnant patients be managed? - Page 3 of 5 - The Hospitalist
Medication for management of pregnancy-induced hypertension
Nutrients, Free Full-Text
Medication for management of pregnancy-induced hypertension
Treatment for Mild Chronic Hypertension during Pregnancy
Medication for management of pregnancy-induced hypertension
Optimal blood pressure target to prevent severe hypertension in pregnancy: A systematic review and meta-analysis
Medication for management of pregnancy-induced hypertension
Pregnancy-induced hypertension: Role of drug therapy and nutrition in the management of hypertension - ScienceDirect
Medication for management of pregnancy-induced hypertension
Pregnancy-Induced Hypertension
Medication for management of pregnancy-induced hypertension
Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets - The Lancet Diabetes & Endocrinology
Medication for management of pregnancy-induced hypertension
PDF) Correlates on the Knowledge and Management Practices on Pregnancy Induced Hypertension (PIH) Among Women in Northern Philippines
Medication for management of pregnancy-induced hypertension
Low Blood Pressure in Pregnancy: Complications and Treatment
Medication for management of pregnancy-induced hypertension
Guidelines for diagnosis and treatment of hypertensive disorders of
Medication for management of pregnancy-induced hypertension
Drug Treatment of Hypertension in Pregnancy
Medication for management of pregnancy-induced hypertension
Hypertension Canada's 2018 Guidelines for the Management of Hypertension in Pregnancy - Canadian Journal of Cardiology
Medication for management of pregnancy-induced hypertension
Hypertensive Disorders of Pregnancy
Medication for management of pregnancy-induced hypertension
Best Practices for Managing Postpartum Hypertension
Medication for management of pregnancy-induced hypertension
Cover Story Gestational Hypertension and Preeclampsia: Nontraditional Risk Factors For Cardiovascular Disease - American College of Cardiology
de por adulto (o preço varia de acordo com o tamanho do grupo)